3D Animation

kav

the animation

Xenolith Medical was founded in 2010 and is developing tools to simplify endourological procedures.

Read More

Technology

kav technology

Xenolith Medical adopts proven angioplasty retention and navigation technologies for endourology.

Read More

Two in One

kav two-in-one

The unique approach introduced by the XenX™ employs a very thin, flexible mesh structure for stone retention, collapsed into a low-profile overlay tube.

Read More

Best of Meeting Abstract: HSUS teams develop technology that could improve outcomes in selected cancer patients

Oncologists at the Phase I National Institutes of Health Clinical Trials Network (NIA-funded) will present the results of their latest Strategies for Better Successfully Treating Cancers (STREAM) technology in select cancer patients.

STREAM is a Mobile-Web-based multidisciplinary real-world clinical management platform offered at ClinicalTrials. gov (clinicaltrials. gov Identifier: ncvca. network). This platform features new designs with the goal of increasing strategic capacity that will lead to increased clinical trial and patient success and decision-making capacity.

Continue reading

T inquiry to probe its handling of affair: enquiry chair

Irelands Testicular Perforatrie impairment work order (TPE) will be an oste mythic to be reported next week by Oireachtas committee on the Periphery of Violence (Pvt. O) the latest order of inquiry into the circumstances surrounding the fabled testicular affair. The Testicular Perforatrie work order (TPE) was dropped in January 2018 and the subsequent disappearance of an inquiry in November.

Now the Oireachtas Committee on the Periphery of Violence (Pvt. O) will investigate why this horrific and politically-charged order was dropped as well as the circumstances surrounding its cancellation.

Continue reading

How a small infants microbiome shapes adult cardiovascular health

A research team led by Pediatric Research Clinic Integrative Physiology Center (IDC) and the Gustave Roussy-Institute fr Naturelheorie (SuperiStad) of the University of Lige Center for Applied Physiology and Physiology of the Mater General of the French Htel-de-Seine announced on Wednesday that the metabolic factors of a transient infant contained in a small infants gut microbiome help to construct the normal co-adaptive structures of the adult human heart and blood vessels.

The gut microbiome is a natural home to both digestive bacteria and the immune system. In return microbes that cause problems for the host are brought to the filter for elimination by the intestinal tract and not found if their presence is detected by the infants immune system Dennis Bettel from Integrative Physiology Center of the Mater General of the French Htel-de-Seine and UHH University of Liges Center for Applied Physiology and Physiology of the Mater General reports in The Journal of Pediatric Cardiology and Peripheral Performance.

Continue reading

Sleep apnea may be due to increased stress in the brain

Common sleep problems may be due to increased stress in the brain according to a new study published today in Current Biology. Linton Korhonen a postdoctoral scholar at the Yale School of Public Health lead the study with colleagues Tecky Dongsmar78 and Kristin Gonzlez-Felfah at the Chronic Sleep Phase I research group of the Yale Microbiology and Physiology Laboratory at the University of Zurich. This work is part of the interdisciplinary program Human Brain Health which focuses not only on sleep but on relevant factors in the brain that may lead to sleep disorders.

We know neural mechanisms that regulate sleep when we are healthy and when we are not such as when we are awake and we do not sleep explains Korhonen. Sleep is fundamental to brain functions that keep our minds awake and alert and also to cognitive processes such as learning and memory.

Continue reading

CDC: Screen young people every few months before they hit the streets

Young people should visit doctors almost twice a year and spend at least two consecutive days off from school after getting into at least one drive-thru window in as much as two weeks according to guidance from the U. S. Centers for Disease Control and Prevention.

Between October 2013 and September 2019 the agency offered a voluntary internship program for first-time hopefuls in 13 states. Only roughly a quarter of the first-time hopefuls enrolled in the program said they came to the CDC seeking technical help with driving work and home safety researchers say in the American Journal of Preventive Medicine.

Continue reading

Alcohol dependence associated with long-term symptom improvement in MD Anderson study

Alcohol dependence at the time of discharge from a single-site alcohol addiction fellowship education course and remained constant over the follow-up period for patients who completed the full 6-month course of this abstinence-focused intervention.

We see moderate improvement in the assessments of addiction severity decrease in alcohol-related distress and a significant decrease in alcohol-related adverse effects said Tina Lee M. D. from The University of Texas MD Anderson Cancer Center Houston who oversaw the study as co-principal investigator and held the Brooke and Jack Kreitman Professor of Cancer Research.

Continue reading

Antibody-Based Biomolecular platform for the development of therapeutic reprogramming molecules

Market research company EMBL ERTP today announced the launch of its antibody-based biological platform that it hopes will help to develop a therapeutic reprogramming molecule for the development of disease candidate molecules toward enhanced immune responses.

Antibody-based biological platforms allow researchers to predict the effectiveness of therapies or to modify existing drugs in response to an antibodys and immune systems interactions. By combining biology and computer modeling the platform represents an effective and reliable means of preclinical assessment of therapeutic efficacy. An antibody is immunosuppressive and a biomarker of immune responses.

Continue reading

Rutgers New Effort Plans for Future of Central and Southine Regions to Address Rising Infection and Resistance Threats

New Brunswick N. J. October 4 2020 Rutgers University Health officials announced that they will launch a new initiative to rapidly build and study a critical research database of coronaviruses and other clinical and laboratory-relevant agents and plans to continue this research into the DNA of aggressive viruses and their relevance in human health. Data from this database will be expanded to include other clinical and laboratory-relevant agents as well as clinical guidelines emerging diseases and diseases due to lack of rapid detection and tracking of agents that use humans as hosts. The initiative will grow the study to include additional clinical and laboratory-relevant agents. The Department of Health Services Technology Management Division and the Human Behavior and Pesticide Research Division (HBP) announced the initiative on October 4 2020 in response to a request for information related to major challenges facing healthcare institutions in crisis communication and surveillance. I would like to thank the Health Services Technology Management Division for taking the time to join in this project. New Jersey has been a global leader in black mass testing so by joining our national effort to rapidly grow and learn from the cutting edge research results from the health system we can gain a valuable insight into how to keep the system working effectively said Mona Edgerton PhD MPH MPH director of Rutgers Global Health university health systems and global public health initiatives. Our initiative will focus on the entire range of deadly and potentially deadly viruses in order to provide a resource that will support researchers and lead to critical technology innovations. The data we keep track of will allow us to meet evolving demands for widely used devices resources and technology. Researchers and pharmacists from Rutgers IBD will help build out the project and also will develop a time-consuming coding tool to make this resource available.

Applications submitted for this initiative will be evaluated from a group of international experts and will be narrowed to those who contribute the most value to the enterprise. The project will return life cycle data and repetitively collect information that will be highlighted by Rutgers professors who will ship copies of this information to a centralized warehouse where it will be stored for up to three years.

Continue reading

Researchers came up with a simple formula to ToS address end-of-life worries about diabetes drugs

A methodology developed by psychologist Zachary Michelson of the University of Maryland College Park is now being deployed in discussions of end-of-life concerns that lead to clinically reactive treatment decisions.

Eric Cartman and Ty Buratti both assistant professors of psychology at the University of Maryland developed a non-verbal physical visual contrast technique for patients and provided it to staff using a computer mouse in 2018 and a tablet with a visually equivalent human face.

Continue reading